Skip to main content

Table 1 Patient, tumor and treatment-related characteristics

From: Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

Characteristics Value
Age, years, median (range) 69 (49–92)
Gender  
Male 55 (78.6%)
Female 15 (21.4)
History of prior TUR-BT  
Initial treatment 50 (71.4%)
Recurrence after previous TURBT 20 (28.6%)
ECOG Performance status  
0 26 (37.1%)
1 43 (61.5%)
2 1 (1.4%)
Comorbidities  
No 20 (28.6%)
Yes 50 (71.4%)
Pathology  
Transitional cell carcinoma 65 (92.9%)
Adenocarcinoma 1 (1.4%)
Other histology or missing record 4 (5.7%)
Grade  
High 55 (78.6%)
Low 1 (1.4%)
Missing record 14 (20.0%)
Clinical T stage  
T2 41 (58.6%)
T3 16 (22.9%)
T4 13 (18.6%)
Focality  
Multifocal 26 (37.2%)
Single 44 (62.8%)
Hydronephrosis  
No 39 (55.7%)
Yes 31 (44.3%)
Procedure before radiotherapy (RT)  
Transurethral resection (TUR) 64 (91.4%)
Partial cystectomy 4 (5.7%)
Cystoscopic biopsy only 2 (2.9%)